This protocol is judged by an institutional evaluate board, an unbiased group that opinions any scientific trials involving human beings. If a study consists of a Schedule I drug, as soon as the board approves the protocol as ethical, the researchers need to apply for an investigational new drug (IND) amount within the FDA.Consequently, medicines i